The Erganoid - 1TM is a medical device - Micro-Bioreactor - able to provide quick and performing ex-vivo tests on human cells to support medics and practitioners in clinical decisions in cancer treatment prescription. It is an effective and reliable mean for significantly reducing the time to treatment and the incidence of negative side effects of unnecessary disease complications and palliative treatments while decreasing considerably the overall healthcare spending in an impactful way.
